Webinars

Cardiac safety assessment, and particularly the evaluation of a drug’s effect on QTc, are required for all new chemical entities. This webinar will discuss strategies for collecting cardiac safety data in early phases in order to complement or help with the design of a definitive QT trial, as well as the circumstances in which early phase QT assessment may be able to replace a standard Thorough QT Trial. learn more

This webinar will discuss how new solutions utilizing wireless temperature monitoring and cloud-based technologies address these issues and provide actionable data for proactive management of the pharmaceutical cold chain. learn more

Understanding the new America Invents Act is key for both US-based companies and others who want to benefit from the huge US Market. Although the move to a “first-to-file” system simplifies the patent process, the need for admissible, credible and authenticated business records associated with your company’s intellectual property has not diminished. learn more

A new approach will combine the shipping information with the temperature date. This data management encompasses the collection, availability and use of data (temperature and shipping), to assure the integrity of the products during transportation and storage.This free webinar will show one ideal way to manage this data in a cost effective way. learn more

This presentation demonstrates how hESC derived cardiomyocytes can be a powerful approach to assessing cardiac drug liabilities. Nick Thomas describes how hESC derived Cytiva Cardiomyocytes: are a valid model of cardiomyocytes from the human heart are compatible with assays routinely used for testing cardiotoxicity together with high-content assays and analysis, can indicate the mechanism of learn more

Contract service providers working with lab professionals are expected to deal with increasing amounts of data in shorter time intervals with either smaller or decreasing budgets. In addition, contract service providers are driven to differentiate their services as well as deliver increasingly high levels of customer service. Superior customer service encompasses providing customized, compliant services in a timely and collaborative manner. learn more

Launching your drug product onto the European Market can present a real challenge if you are not familiar with country specific requirements, particularly if you are based in the U.S. With its 27 member states, numerous official working languages and complex regulatory framework, this webinar will clarify the key requirements for a successful EU product launch. learn more

This webinar will focus on reducing your facility’s footprint for leaner operation and focusing on new areas within compound management. learn more

This webinar will cover applying GS1 bar code and RFID technology within the healthcare industry to track devices and processes to save costs and time (and avoid serious adverse effects) and utilising unique identifiers in compliance with regulations and complimentary healthcare standards to promote standardisation. learn more

Results of a recent industry wide survey show that biopharmaceutical companies are planning to make a gradual increase in investment in new, predictive safety technologies. While 53% of respondents say their organization’s spending levels will remain “about the same,” 26% claim they will increase their spending. The types of technologies that are generating the most interest (and investment) from biopharmaceutical companies are: learn more

As global regulation on serialization is reaching the next level of maturity, industry is bound to take serialization to the next level. This will involve more than just straightforward 'printing / reading / storing as multinational, cross-border supplying pharma faces a huge variety of different requirement. In the end, only true global suppliers that can offer a versatile yet highly standardized solution are able to support the industry to meet the regulatory demands learn more